Corrigendum shows Vernodalin reduces cardiotoxicity in rats with myocardial infarction, highlighting its role in inflammation.
In the published version of the article [1], an error was identified in the Ethics Approval and Consent to Participate section. Specifically, the name of the approving institution was incomplete. This corrigendum is issued to correct the record. The scientific content and conclusions of the article remain unchanged. The original article can be found online at https://www.benthamscience.com/article/140805 Details of the correction: Original: ETHICS APPROVAL AND CONSENT TO PARTICIPATE The animals were maintained as per the rules of the Histogenotec Ethics Committee (No. A3555997). Corrected: ETHICS APPROVAL AND CONSENT TO PARTICIPATE The animals were maintained as per the rules of the Medical Ethics Committee of Histogenetics (India) Private Limited, Tamil Nadu, India (Re no: No. A3555997). The publisher apologizes for any inconvenience caused.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: